Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof
CA 2472190 C · Owner: Msika, Philippe · Inventors: Piccirilli, Antoine; Msika, Philippe; Piccardi, Nathalie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a composition containing at least an oxazolin optionally combined with at least a compound such as a metalloprotease inhibitor a PKC inhibitor, an anti-inflammatory agent a soothing agent, an immunosuppressor, an ion chelating agent an alkanolamide, an oxazolidinone and a carbamic acid derivative. The invention also concerns the use of such a composition as medicine in particular for preventing or treating skin pathologies of allergic and/or inflammatory and/or irritative origin or resulting from a danger signal. The invention further concerns a method for cosmetic treatment of sensitive irritated, intolerant, allergy-prone, ageing skin and/or mucosa exhibiting skin …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 27, 2002 and granted April 24, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 27, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 27, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.